°×С½ãÈýФÈýÆڱسöÒ»ÆÚ¿ª½±

Jump to Main Content

Newsroom

Submit
Reset

ASH Recognizes 2024 Quality Improvement Champions

Aug 27
2024

ASH Quality Improvement Champions are standardizing treatment, implementing clinical guidelines to improve patient safety (WASHINGTON, August 27, 2024) – The °×С½ãÈýФÈýÆڱسöÒ»ÆÚ¿ª½± (ASH) recognizes Josie Fernandez Sanchez, MD, of Texas Chil...

Read more

ASH Announces New ASH-Harold Amos Medical Faculty Development Program Hematology Scholar

Aug 21
2024

(WASHINGTON, August 21, 2024) — The °×С½ãÈýФÈýÆڱسöÒ»ÆÚ¿ª½± (ASH) is pleased to announce the recipient of the ASH-Harold Amos Medical Faculty Development Program award, Michelle Schoettler, MD, of Children’s Healthcare of Atlanta&r...

Read more

Over Half of Iron Deficiency Cases in Large Health System Still Unresolved at Three Years

Aug 15
2024

Study underscores the need for improvements in the proper recognition and timely treatment of more of iron deficiency, especially among female and Black patients (WASHINGTON, August 15, 2024) – Over half of people with iron deficiency were fo...

Read more

External Mentorship Key in Encouraging Trainees to Pursue Classical Hematology

Aug 01
2024

Program could help combat classical hematology’s diminishing workforce   (WASHINGTON, August 1, 2024) — In a year-long pilot program, external mentorship increased confidence, furthered career development, and facilitated networking opportuniti...

Read more

FDA Mandated CAR T Monitoring Period Could be Halved

Jul 24
2024

CAR-T toxicities are rare after two weeks in diffuse large B-cell non-Hodgkin lymphoma treatment, and shorter restriction periods could increase overall treatment accessibility (WASHINGTON, July 24, 2024) – In patients with diffuse large B-cell non-H...

Read more

Hydroxyurea Does Not Reduce Ovarian Reserve

Jul 18
2024

Study suggests that hydroxyurea alters the developmental process of ovarian follicles, but not their quantity (WASHINGTON, July 18, 2024) â€” In female patients living with sickle cell disease (SCD), hydroxyurea had no effect on ovarian reserve,...

Read more

Safe, Successful Pregnancies Possible After AlloHCT

Jul 15
2024

Findings refute former consensus that pregnancies post-transplant are nearly impossible, highlight need for increased fertility counseling   (WASHINGTON, July 15, 2024) — Despite treatment-related fertility challenges, female patients can become...

Read more

Reduced Infections Seen in CLL and NHL Patients Undergoing Immunoglobin Testing

Jun 21
2024

Study findings suggest that clear clinician guidance on testing and treatment may save lives (WASHINGTON, June 21, 2024) – Patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHLs) who received frequent tests for immunoglobu...

Read more

ASH Announces 2024 Honorific Award Recipients

Jun 18
2024

(WASHINGTON, June 18, 2024) — The °×С½ãÈýФÈýÆڱسöÒ»ÆÚ¿ª½± (ASH) will recognize exemplary hematologists who have made significant contributions to the field with several honorific awards at the 2024 ASH Annual Meeting and Exposition in San Dieg...

Read more

Afib Patients on Low Doses of Blood Thinners Have More Bleeding Episodes Than Those on Standard Doses

Jun 06
2024

Risk of bleeding highest in first three months of treatment, even in patients on low doses of direct oral anticoagulants    (WASHINGTON, June 6, 2024) – Patients with atrial fibrillation (Afib) who took low doses of blood-thinning me...

Read more